12th World ADC London 2022

Memo

With the approvals of Zynlonta and Tivdak within the last 12 months there are now 11 commercially available ADCs on the market. Furthermore, recent Enhertu and Polivy data suggests that ADCs could be soon be used as earlier line treatments to improve patient outcomes sooner. Undoubtedly, the momentum and inspiration that ADCs and ADC developers are gathering means that it's an incredibly exciting time for the entire community. Covering all aspects of ADC development from discovery through to late stage manufacturing, now is the time to join the biggest community of thought leaders and experts within the ADC space in Europe. Through in-depth research with the industry, our four-day, four-streamed agenda has been created to address the most important challenges in bringing next generation of clinically impactful ADCs to the hands of patients. Exploring novel linker-payloads, overcoming critical in vivo and translational difficulties, optimising dosage and patient selection within the clinic, streamlining process development and achieving pure and consistent drug substance in early and late clinical/commercial settings; wherever your interest and expertise lies, we have it covered! You cannot afford to miss World ADC London 2022 as we bring you more speakers, content and networking opportunities than ever before! URLs:Tickets: https://go.evvnt.com/944846-2?pid=5569 Brochure: https://go.evvnt.com/944846-3?pid=5569 LinkedIn: https://go.evvnt.com/944846-4?pid=5569  Twitter: https://go.evvnt.com/944846-5?pid=5569 Date and Time: On Tue, Mar 29, 22 ( 8:00 AM) - Fri, Apr 1, 22 ( 4:00 PM) Venue details: Hotel Novotel London West, International Ctre, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom Prices:Drug Developer Pricing - Main 2 Day Scientific Program plus Seminar Day and Workshop Day (Full 4 Day Access Pass): GBP 4495.00,Drug Developer Pricing - Conference plus Seminar day (3 Day Pass): GBP 3497.00,Drug Developer Pricing - Conference plus Workshop Day (3 Day Pass): GBP 3497.00,Drug Developer Pricing - Conference only (2 day pass): GBP 2499.00,Academic Pricing - Main 2 Day Scientific Program plus Seminar Day and Workshop Day (Full 4 Day Access Pass): GBP 3795.00,Academic Pricing - Conference plus Seminar day (3 Day Pass): GBP 2897.00,Academic Pricing - Conference plus Workshop Day (3 Day Pass): GBP 2897.00,Academic Pricing - Conference only (2 day pass): GBP 1999.00 Speakers: Sunil Verma, Global Head and Head of Breast Cancer Strategy, AstraZeneca, Daejin Abidoye, SVP Oncology Therapeutics, Gilead Sciences, Heather Van Epps, Director, Research Early-Stage Clinical Programs, Seagen, Edith Perez, Chief Medical Officer, Bolt Biotherapeutics, Gilles Gallant, SVP Global Head, Oncology Department, Oncology RandD, Daiichi Sankyo, Raffaella Faggioni, VP, Clinical and Translational Pharmacology, Exelixis, Thomas Pillow, Principal Scientist, Genentech, Jan-Oliver Schwabe, Senior Site Manager, F.Hoffman-La Roche, Firelli Alonso, Senior Director, External Supply, Pfizer, Dario Neri, Chief Executive Officer, Philogen